Search

everythinglearnresearchcommunity

for

Search:↓

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Feather patterns form through genetic and epigenetic controls, with cells self-organizing into periodic patterns.

Hair color production is closely linked to the active growth phase of hair in mice and may also influence hair growth itself.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Shift nurses show altered body temperature and stress hormone levels, suggesting their body clocks adjust to irregular schedules.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

ATP increases melanin production in skin after UV exposure, with the P2X7 receptor being crucial for this process.

Dopamine stops hair growth and pigment production in human scalp hair follicles.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

Stressed fibroblasts greatly increase melanin production in hair, skin, and eye cells, mainly due to a growth factor called bFGF.

A young man with an eating disorder had a life-threatening adrenal crisis due to an autoimmune condition, highlighting the need for better education on managing hormone treatments.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Stress hormone CRF can cause hair loss by affecting hair growth cells and hormones.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Rice bran extract boosts melanin production in hair follicles.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.